AKTX · Akari Therapeutics Plc
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least a one-year period following the issuance of these condensed consolidated financial statements.”View the 10-Q filed May 19, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-07 | Patel Samir Rashmikant |
Director, 10% Owner |
Convert↑
Filing footnotes — Pre-Funded Warrant to purchase ADSs (Indirect)
On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 5,799 ADSs, at a purchase price of $16.16 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) warrants to purchase up to 5,799 ADSs. The pre-funded warrants became exercisable upon shareholder approval, which was obtained on March 2, 2026. The pre-funded warrants remain exercisable until fully exercised. |
Pre-Funded Warrant to purchase ADSs
(I)
|
5,799 |
| 2026-07-07 | Patel Samir Rashmikant |
Director, 10% Owner |
Convert↑
|
American Depositary Shares representing Ordinary Shares
(I)
|
15,466 |
| 2026-07-07 | Patel Samir Rashmikant |
Director, 10% Owner |
Convert↑
|
American Depositary Shares representing Ordinary Shares
(I)
|
5,799 |
| 2026-07-07 | Patel Samir Rashmikant |
Director, 10% Owner |
Convert↑
Filing footnotes — Pre-Funded Warrant to purchase ADSs (Indirect)
The combined purchase price per one pre-funded warrant and accompanying Series G Warrant was $16.16. The pre-funded warrants became exercisable upon shareholder approval, which was obtained on March 2, 2026. The pre-funded warrants remain exercisable until fully exercised. |
Pre-Funded Warrant to purchase ADSs
(I)
|
15,466 |
| 2026-07-07 | Patel Samir Rashmikant |
Director, 10% Owner |
Convert↑
|
American Depositary Shares representing Ordinary Shares
(I)
|
1,209 |
| 2026-07-07 | Patel Samir Rashmikant |
Director, 10% Owner |
Convert↑
Filing footnotes — Pre-Funded Warrant to purchase American Depositary Shares (Indirect)
Each American Depositary Share ("ADS") represents 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The pre-funded warrants remain exercisable until fully exercised. |
Pre-Funded Warrant to purchase American Depositary Shares
(I)
|
1,209 |
| 2026-06-24 | Gaslightwala Abizer |
Director, CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On April 1, 2026, the reporting person was granted an option to purchase 15,000 American Depositary Shares, with each American Depositary Share representing 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The option vests in three installments based on the closing of qualified financings of at least $15,000,000 in gross proceeds on or before June 30, 2026. The Issuer closed a qualified financing of $5,500,000, resulting in the vesting of the option as to 5,500 American Depositary Shares. |
Stock Option (Right to Buy)
|
5,500 |
| 2026-06-24 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026. |
American Depositary Shares representing Ordinary Shares
|
1,395 |
| 2026-06-24 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026. |
American Depositary Shares representing Ordinary Shares
|
2,539 |
| 2026-06-24 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026. |
American Depositary Shares representing Ordinary Shares
|
1,570 |
| 2026-06-24 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026. |
American Depositary Shares representing Ordinary Shares
|
3,725 |
| 2026-06-24 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026. |
American Depositary Shares representing Ordinary Shares
|
1,000 |
| 2026-06-24 | Gaslightwala Abizer |
Director, CEO |
Award↑
|
Stock Option (Right to Buy)
|
15,563 |
| 2026-06-24 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026. |
American Depositary Shares representing Ordinary Shares
|
7,353 |
| 2026-06-24 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026. |
American Depositary Shares representing Ordinary Shares
|
1,248 |
| 2025-12-16 | Neal James R |
Director, CEO |
Buy↑
Filing footnotes — Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 3,093 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 3,219 ADSs (the "Note Exchange Unregistered Warrants"). The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Warrants to purchase ADRs
|
3,093 |
| 2025-12-16 | Prudo-Chlebosz Raymond |
Director |
Buy↑
Filing footnotes — Warrants to purchase American Depositary Shares ("ADRs") (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 618,658 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 618,658 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Warrants to purchase American Depositary Shares ("ADRs")
|
618,658 |
| 2025-12-16 | Gaslightwala Abizer |
Director, CEO |
Buy↑
Filing footnotes — Warrants to purchase American Depositary Shares ("ADRs") (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 309,328 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 309,328 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFW shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Warrants to purchase American Depositary Shares ("ADRs")
|
309,328 |
| 2025-12-16 | Huh Hoyoung |
Director |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 618,658 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 618,658 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. Conversion Exercise Price of Security is $0.00001 The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
618,658 |
| 2025-12-16 | Patel Samir Rashmikant |
Director, 10% Owner |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Indirect)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 231,997 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 241,437 ADSs (the "Note Exchange Unregistered Warrants"). Conversion Exercise Price of Security is $0.00001 The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
(I)
|
231,997 |
| 2025-12-16 | Bazemore Robert B |
Director |
Buy↑
Filing footnotes — Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 30,932 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 32,191 ADSs (the "Note Exchange Unregistered Warrants"). The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Warrants to purchase ADRs
|
30,932 |
| 2025-12-16 | Huh Hoyoung |
Director |
Buy↑
Filing footnotes — Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 3,093,293 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 3,219,160 ADSs (the "Note Exchange Unregistered Warrants"). The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Warrants to purchase ADRs
|
3,093,293 |
| 2025-12-16 | Patel Sandip I |
Director |
Buy↑
Filing footnotes — Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 154,664 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 160,958 ADSs (the "Note Exchange Unregistered Warrants"). The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Warrants to purchase ADRs
|
154,664 |
| 2025-12-16 | Bazemore Robert B |
Director |
Buy↑
Filing footnotes — Warrants to purchase American Depositary Shares ("ADRs") (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 123,731 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 123,731 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Warrants to purchase American Depositary Shares ("ADRs")
|
123,731 |
| 2025-12-16 | Farag Kameel D. |
Director |
Buy↑
Filing footnotes — Warrants to purchase American Depositary Shares ("ADRs") (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 24,745 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 24,745 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the Private Placement Unregistered Warrants remaining exercisable until fully exercised. |
Warrants to purchase American Depositary Shares ("ADRs")
|
24,745 |
| 2025-12-16 | Patel Sandip I |
Director |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 247,462 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 247,462 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. Conversion Exercise Price of Security is $0.00001 The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
247,462 |
| 2025-12-16 | Neal James R |
Director, CEO |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 3,093 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 3,219 ADSs (the "Note Exchange Unregistered Warrants"). Conversion Exercise Price of Security is $0.00001 The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
3,093 |
| 2025-12-16 | Gaslightwala Abizer |
Director, CEO |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 773,323 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 804,790 ADSs (the "Note Exchange Unregistered Warrants"). Conversion Exercise Price of Security is $0.00001 The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
773,323 |
| 2025-12-16 | Neal James R |
Director, CEO |
Buy↑
Filing footnotes — Warrants to purchase American Depositary Shares ("ADRs") (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 2,473 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 2,473 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Warrants to purchase American Depositary Shares ("ADRs")
|
2,473 |
| 2025-12-16 | Patel Samir Rashmikant |
Director, 10% Owner |
Buy↑
Filing footnotes — Warrants to purchase ADRs (Indirect)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 231,997 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 241,437 ADSs (the "Note Exchange Unregistered Warrants"). The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Warrants to purchase ADRs
(I)
|
231,997 |
| 2025-12-16 | Huh Hoyoung |
Director |
Buy↑
Filing footnotes — Warrants to purchase American Depositary Shares ("ADRs") (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 618,658 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 618,658 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Warrants to purchase American Depositary Shares ("ADRs")
|
618,658 |
| 2025-12-16 | Bazemore Robert B |
Director |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 30,932 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 32,191 ADSs (the "Note Exchange Unregistered Warrants"). Conversion Exercise Price of Security is $0.00001 The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
30,932 |
| 2025-12-16 | Gaslightwala Abizer |
Director, CEO |
Buy↑
Filing footnotes — Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 773,323 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 804,790 ADSs (the "Note Exchange Unregistered Warrants"). The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Warrants to purchase ADRs
|
773,323 |
| 2025-12-16 | Patel Samir Rashmikant |
Director, 10% Owner |
Buy↑
Filing footnotes — Warrants to purchase American Depositary Shares ("ADRs") (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 618,658 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 618,658 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Warrants to purchase American Depositary Shares ("ADRs")
|
618,658 |
| 2025-12-16 | Prudo-Chlebosz Raymond |
Director |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 386,661 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 402,395 ADSs (the "Note Exchange Unregistered Warrants"). Conversion Exercise Price of Security is $0.00001 The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
386,661 |
| 2025-12-16 | Gaslightwala Abizer |
Director, CEO |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 309,328 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 309,328 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. Conversion Exercise Price of Security is $0.00001 The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFW shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
309,328 |
| 2025-12-16 | Farag Kameel D. |
Director |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 24,745 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 24,745 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. Conversion Exercise Price of Security is $0.00001 The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the Private Placement Unregistered Warrants remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
24,745 |
| 2025-12-16 | Prudo-Chlebosz Raymond |
Director |
Buy↑
Filing footnotes — Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 386,661 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 402,395 ADSs (the "Note Exchange Unregistered Warrants"). The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Warrants to purchase ADRs
|
386,661 |
| 2025-12-16 | Patel Sandip I |
Director |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 154,664 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 160,958 ADSs (the "Note Exchange Unregistered Warrants"). Conversion Exercise Price of Security is $0.00001 The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
154,664 |
| 2025-12-16 | Prudo-Chlebosz Raymond |
Director |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 618,658 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 618,658 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. Conversion Exercise Price of Security is $0.00001 The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
618,658 |
| 2025-12-16 | Bazemore Robert B |
Director |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 123,731 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 123,731 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. Conversion Exercise Price of Security is $0.00001 The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
123,731 |
| 2025-12-16 | Patel Samir Rashmikant |
Director, 10% Owner |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 618,658 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 618,658 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. Conversion Exercise Price of Security is $0.00001 The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
618,658 |
| 2025-12-16 | Huh Hoyoung |
Director |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 3,093,293 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 3,219,160 ADSs (the "Note Exchange Unregistered Warrants"). Conversion Exercise Price of Security is $0.00001 The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
3,093,293 |
| 2025-12-16 | Patel Sandip I |
Director |
Buy↑
Filing footnotes — Warrants to purchase American Depositary Shares ("ADRs") (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 247,462 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 247,462 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Warrants to purchase American Depositary Shares ("ADRs")
|
247,462 |
| 2025-12-16 | Neal James R |
Director, CEO |
Buy↑
Filing footnotes — Pre-Funded Warrants to purchase ADRs (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 2,473 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 2,473 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. Conversion Exercise Price of Security is $0.00001 The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised. |
Pre-Funded Warrants to purchase ADRs
|
2,473 |
| 2025-11-01 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on January 1, 2026. |
American Depositary Shares representing Ordinary Shares
|
32,000 |
| 2025-11-01 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on February 15, 2026. |
American Depositary Shares representing Ordinary Shares
|
26,619 |
| 2025-10-22 | Farag Kameel D. |
Director |
Award↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on October 31, 2025. |
American Depositary Shares representing Ordinary Shares
|
6,277 |
| 2025-10-22 | Farag Kameel D. |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-08-25 | Gaslightwala Abizer |
Director, CEO |
Buy↑
Filing footnotes — American Depositary Shares representing Ordinary Shares (Direct)
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.89 to $0.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote. |
American Depositary Shares representing Ordinary Shares
|
3,000 |